8g9HezBKD9BH3FZNfNKM

(PPHM, OWW, DSCO) CRWENewswire Stocks In Action

  • 0
  • 0

Peregrine Pharmaceuticals Inc - PPHM - reported preliminary results related with its Bavituximab from a randomized Phase II trial showing a 50% improvement in overall tumor response rates in non-small cell lung cancer patients

06 Dec 2011

70 Visualizações

dsco, oww, pphm

Estatísticas do vídeo

Mostrar:

Comentários

Vídeos em Destaque